# A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

> clinical trial · VERIFIED · 2025-03-28

Status: COMPLETED · Sponsor: Neurotech Pharmaceuticals · Condition: Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage

- Company: Neurotech Pharmaceuticals
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT00447954

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.